Cargando…

Evaluation of RNA Blood Biomarkers in the Parkinson’s Disease Biomarkers Program

There is a high misdiagnosis rate between Parkinson’s disease (PD) and atypical parkinsonian disorders (APD), such as progressive supranuclear palsy (PSP), the second most common parkinsonian syndrome. In our earlier studies, we identified and replicated RNA blood biomarkers in several independent c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santiago, Jose A., Bottero, Virginie, Potashkin, Judith A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986959/ https://www.ncbi.nlm.nih.gov/pubmed/29896099 http://dx.doi.org/10.3389/fnagi.2018.00157

Ejemplares similares

Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
por: Santiago, Jose A., et al.
Publicado: (2017)

Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology
por: Santiago, Jose A., et al.
Publicado: (2017)

Transcriptomic and Network Analysis Highlight the Association of Diabetes at Different Stages of Alzheimer’s Disease
por: Santiago, Jose A., et al.
Publicado: (2019)

Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson’ Disease
por: Santiago, Jose A., et al.
Publicado: (2017)

Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
por: Santiago, Jose A., et al.
Publicado: (2015)

Key Disease Mechanisms Linked to Amyotrophic Lateral Sclerosis in Spinal Cord Motor Neurons
por: Bottero, Virginie, et al.
Publicado: (2022)

Transcriptomic and Network Meta-Analysis of Frontotemporal Dementias
por: Bottero, Virginie, et al.
Publicado: (2021)

Integrative transcriptomic meta-analysis of Parkinson’s disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson’s disease
por: Santiago, Jose A., et al.
Publicado: (2016)

Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's Disease
por: Santiago, Jose A., et al.
Publicado: (2014)

Meta-Analysis of Gene Expression Changes in the Blood of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Dementia
por: Bottero, Virginie, et al.
Publicado: (2019)

The emerging role of nutrition in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2014)

A Comparison of Gene Expression Changes in the Blood of Individuals Consuming Diets Supplemented with Olives, Nuts or Long-Chain Omega-3 Fatty Acids
por: Bottero, Virginie, et al.
Publicado: (2020)

Transcriptomic and Network Analysis Identifies Shared and Unique Pathways across Dementia Spectrum Disorders
por: Santiago, Jose A., et al.
Publicado: (2020)

Current Challenges Towards the Development of a Blood Test for Parkinson’s Disease
por: Santiago, Jose A., et al.
Publicado: (2014)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Erratum: The promise of neuroprotective agents in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2013)

The Impact of Disease Comorbidities in Alzheimer's Disease
por: Santiago, Jose A., et al.
Publicado: (2021)

Bioinformatic Analysis Reveals Phosphodiesterase 4D-Interacting Protein as a Key Frontal Cortex Dementia Switch Gene
por: Potashkin, Judith A., et al.
Publicado: (2020)

Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer’s patients
por: Potashkin, Judith A., et al.
Publicado: (2019)

Physical activity and lifestyle modifications in the treatment of neurodegenerative diseases
por: Santiago, Jose A., et al.
Publicado: (2023)

Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes
por: Santiago, Jose A., et al.
Publicado: (2013)

Key Disease Mechanisms Linked to Alzheimer’s Disease in the Entorhinal Cortex
por: Bottero, Virginie, et al.
Publicado: (2021)

Sex-specific transcriptional rewiring in the brain of Alzheimer’s disease patients
por: Santiago, Jose A., et al.
Publicado: (2022)

Recent Advances in Biomarkers for Parkinson’s Disease
por: He, Runcheng, et al.
Publicado: (2018)

Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
por: Emamzadeh, Fatemeh N., et al.
Publicado: (2018)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
por: Lin, Chin-Hsien, et al.
Publicado: (2018)

Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
por: Potashkin, Judith A., et al.
Publicado: (2012)

Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease
por: Li, Tianbai, et al.
Publicado: (2018)

Blood SSR1: A Possible Biomarker for Early Prediction of Parkinson’s Disease
por: Zhang, Wen, et al.
Publicado: (2022)

Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease
por: Novak, Kevin, et al.
Publicado: (2022)

Integrated Analysis and Identification of Novel Biomarkers in Parkinson’s Disease
por: Chi, Jieshan, et al.
Publicado: (2018)

Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease
por: Roser, Anna Elisa, et al.
Publicado: (2018)

Bone-Derived Factors as Potential Biomarkers for Parkinson’s Disease
por: Lin, Yuwan, et al.
Publicado: (2021)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Neurofilament light as a biomarker for motor decline in Parkinson’s disease
por: Liu, Yumei, et al.
Publicado: (2022)

Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease
por: Jiménez-Jiménez, Félix J., et al.
Publicado: (2014)

MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease
por: Arshad, Ahmad R., et al.
Publicado: (2017)

Blood biomarker for Parkinson disease: peptoids
por: Yazdani, Umar, et al.
Publicado: (2016)

Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
por: Ganguly, Upasana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_osut8btbi6pq3atm0vo7sr8kev